CONMED CORPORATION Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
CONMED CORPORATION (CNMD) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $17.66 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-29
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $17.66M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $9.31M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $18.02M.
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $26.65M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $17.66M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $9.31M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $18.02M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $26.65M 10-Q · filed 2025-05-01 |
| 2024-09-30 | $8.76M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $17.48M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $26.07M 10-Q · filed 2024-04-25 |
| 2023-09-30 | $8.84M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $17.67M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $26.45M 10-Q · filed 2023-04-27 |
| 2022-09-30 | $8.99M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $17.73M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $22.82M 10-Q · filed 2022-05-05 |
| 2021-09-30 | $8.69M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $16.91M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $25.12M 10-Q · filed 2021-04-29 |
| 2020-09-30 | $8.47M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $17.02M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $25.55M 10-Q · filed 2020-04-30 |
| 2019-09-30 | $8.13M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $16.42M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $25.26M 10-Q · filed 2019-04-26 |
| 2018-09-30 | $5.99M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $11.95M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $17.52M 10-Q · filed 2018-04-26 |
| 2017-09-30 | $5.46M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $10.36M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $15.40M 10-Q · filed 2017-04-27 |
| 2016-09-30 | $4.98M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $9.99M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $15.20M 10-Q · filed 2016-05-02 |
| 2015-09-30 | $2.94M 10-Q · filed 2015-10-23 |
| 2014-09-30 | $13.04M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $13.02M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $13.13M 10-Q · filed 2014-04-25 |
| 2013-09-30 | $13.41M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $7.87M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $7.73M 10-Q · filed 2013-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |